{"id":386550,"date":"2018-11-14T00:00:00","date_gmt":"2018-11-14T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360va0020-medtech-vascular-access-devices-medtech-360-market-analysis-europe-supplemental-2019\/"},"modified":"2026-04-14T10:06:42","modified_gmt":"2026-04-14T10:06:42","slug":"m360va0020-medtech-vascular-access-devices-medtech-360-market-analysis-europe-supplemental-2019","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360va0020-medtech-vascular-access-devices-medtech-360-market-analysis-europe-supplemental-2019\/","title":{"rendered":"Vascular Access Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2019"},"content":{"rendered":"<p>The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of\u00a0PICCs in all European countries, as well as the rising adoption of new technologies such as power-injectable devices, and devices with antimicrobial coatings. However, market revenues will be hindered to some extent by declining\u00a0ASPs resulting from pricing pressures and increasing competition. Overall, rising unit sales\u2014predominantly due to an aging population\u2014and the uptake of premium-priced products will spur revenue growth in the European vascular access device market.<\/p>\n<p>This Medtech 360 Report\u00a0provides high-level market metrics for the vascular access device\u00a0market\u00a0in Europe, including country-level data for major countries and aggregate data for the rest of Europe,\u00a0across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386550","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-vascular-access-devices","medtech-geography-europe","medtech-product-medtech-360","medtech-date-918"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386550\/revisions"}],"predecessor-version":[{"id":388053,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386550\/revisions\/388053"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}